Explorer les evidences

77 %Of the 5,500 people living with HIV aged ≥15 years on first-line antiretroviral therapy at one health facility in Kenya, 77% had transitioned to optimized antiretroviral drugs.

KenyaVIH/sidapublié 2020PloS onePubMeddocument de 4 observations

25,2 %HIV positivity yield in the general population was 25.2% in year 1 and 24.1% in year 2 of index testing implementation in Nairobi County.

KenyaVIH/sidapublié 2023Tropical medicine & international health : TM & IHPubMeddocument de 8 observations

0,33 proportionA small share of women living with HIV achieved high proportion of days covered (PDC) with antiretroviral therapy ≥0.90 during the last 24 weeks of pregnancy: 0.33 in the standard care arm and 0.24 in the intervention arm.

KenyaVIH/sidapublié 2023BMC infectious diseasesPubMeddocument de 4 observations

14 %Among 176 included decedents aged 28 days to less than 5 years, 14% (n = 25) were HIV-infected.

KenyaVIH/sidapublié 2022AIDS (London, England)PubMeddocument de 8 observations

0,67 odds_ratioExperiencing HIV stigma was associated with a 0.67 decreased odds of ART adherence (95% CI: 0.56–0.80).

KenyaVIH/sidapublié 2022AIDS carePubMeddocument de 4 observations

7,7 per_100_person-yearsAmong 1335 HIV-1-seronegative women monitored for a median of 566 days in Mombasa, Kenya, 265 women seroconverted to HIV-1, corresponding to an incidence rate of 7.7 per 100 person-years.

KenyaVIH/sidapublié 2007The Journal of infectious diseaseseurope_pmcdocument de 3 observationsDOI 10.1086/511278

19,16 odds_ratioHIV infection with antiretroviral therapy (ART) use was associated with ocular surface squamous neoplasia (OSSN) with an odds ratio of 19.16.

Kenyaocular surface squamous neoplasia (OSSN) · VIH/sidapublié 2016Tropical medicine & international health : TM & IHeurope_pmcdocument de 10 observations

80 infantsOf 626 enrolled infants, 80 (12.8%) received no point-of-care HIV testing.

KenyaVIH/sidapublié 2020PloS onePubMeddocument de 13 observations

405 womenA total of 405 women contributed 2750 vaginal samples over 606 person-years of follow-up.

KenyaVIH/sidapublié 2016Sexually transmitted diseaseseurope_pmcdocument de 3 observations

51,7 daysKakamega County had the longest mean DNA-PCR turnaround time at 51.7 days in Vihiga, Bungoma, Kakamega and Busia counties in Kenya between January 2012 and June 2013.

KenyaVIH/sidaobservé January 2012 to June 2013publié 2024PloS onePubMeddocument de 7 observations

5 weeksEarly infant HIV seroconversion occurred at approximately 5 weeks in Homa Bay Town, consistent with intrauterine or intrapartum transmission.

KenyaVIH/sidapublié 2026International Journal of Community Medicine and Public HealthOpenAlexdocument de 4 observationsDOI 10.18203/2394-6040.ijcmph20260667

0,89 ratioHIV incidence rate ratio was 0.89 for DCP without cabotegravir relative to no DCP.

KenyaVIH/sidapublié 2025The lancet. HIVPubMeddocument de 11 observations

1,53 aRRIn Siaya County, western Kenya, clients aged over 15 years who received home-based HIV testing between May 2016 and July 2017 showed an adjusted relative risk (aRR) of 1.53 for HIV-positive diagnosis among those who had been tested for HIV more than 12 months ago.

KenyaVIH/sidaobservé May 2016 to July 2017publié 2021BMC public healthPubMeddocument de 4 observations

38 %Thirty-eight percent of ART-naïve women from the Pumwani Sex Worker cohort of Nairobi, Kenya had at least one WHO surveillance drug resistance mutation.

KenyaVIH/sidapublié 2022VirusesPubMeddocument de 4 observations

42,4 %Testing among eligible partners in the general population increased from 42.4% (1471/3470) to 74.9% (6114/8159) between year 1 and year 2 of index testing implementation in Nairobi County.

KenyaVIH/sidapublié 2023Tropical medicine & international health : TM & IHPubMeddocument de 8 observations

34,7 %HIV self-testing (HIVST) was accepted at 34.7% of PrEP follow-up visits among young women in Kisumu, Kenya, between February and November 2019.

KenyaVIH/sidaobservé February to November 2019publié 2020Journal of the International AIDS SocietyPubMeddocument de 7 observations

52 %By 2012, an estimated 52% of HIV-positive individuals in the community were receiving antiretroviral therapy in Mombasa District, Kenya.

KenyaVIH/sidaobservé 2012publié 2015AIDS (London, England)europe_pmcdocument de 4 observations

42 %Among 1,384 young adults living with HIV in Western Kenya, the prevalence of lifetime violence was 42% in male patients 20 years and older.

KenyaVIH/sidapublié 2026The Journal of the Association of Nurses in AIDS Care : JANACPubMeddocument de 8 observations

18,4 %Total HIV prevalence was 18.4% in the general population sample of women aged 15–49 in the Siaya HDSS in western Kenya in 2018.

KenyaVIH/sidaobservé 2018publié 2023PloS onePubMeddocument de 2 observations

50 %Among 10 enrollees who were unwilling to participate, five (50%) cited fear of vaccine adverse effects.

KenyaVIH/sidaobservé From February 2017 to May 2018publié 2026BMC public healthPubMeddocument de 10 observations

87 %After 19 months of follow-up, 65 out of 75 participants living with HIV (87%) were active in care.

KenyaVIH/sidapublié 2023BMC health services researchPubMeddocument de 12 observations

42 %Among HIV-infected women self-reporting pregnancy/live birth, prevalence of viral suppression was 42% at baseline in intervention communities.

KenyaVIH/sidapublié 2020AIDS (London, England)PubMeddocument de 8 observations

18 US$The mean total unit cost of post-exposure prophylaxis (PEP) was US$18 in Kenya.

KenyaVIH/sidaobservé 2019publié 2023BMC health services researchPubMeddocument de 11 observations

57,7 %Recent significant life-events were prevalent in 57.7% of youth aged 15–24 years living with HIV in rural Kenya and Uganda.

KenyaVIH/sidapublié 2023AIDS carePubMeddocument de 7 observations

0,73 prevalence_ratioNewly-diagnosed HIV was not associated with consistent versus inconsistent condom use, with a prevalence ratio of 0.73 (95% CI 0.25–2.10).

KenyaVIH/sidapublié 2024PloS onePubMeddocument de 6 observations